Russell Investments Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.4M | Sell |
1,038,101
-13,216
| -1% | -$699K | 0.05% | 378 |
|
|
2026
Q1 | $57.9M | Buy |
1,051,317
+122,335
| +13% | +$6.63M | 0.06% | 314 |
|
|
2025
Q4 | $45.6M | Sell |
928,982
-28,510
| -3% | -$1.33M | 0.05% | 381 |
|
|
2025
Q3 | $41.3M | Sell |
957,492
-143,195
| -13% | -$5.59M | 0.05% | 395 |
|
|
2025
Q2 | $42.3M | Sell |
1,100,687
-151,013
| -12% | -$5.77M | 0.05% | 362 |
|
|
2025
Q1 | $48.5M | Buy |
1,251,700
+224,860
| +22% | +$8.23M | 0.07% | 307 |
|
|
2024
Q4 | $34.7M | Sell |
1,026,840
-10,029
| -1% | -$361K | 0.05% | 399 |
|
|
2024
Q3 | $42.4M | Buy |
1,036,869
+14,652
| +1% | +$599K | 0.06% | 330 |
|
|
2024
Q2 | $39.4M | Sell |
1,022,217
-94,995
| -9% | -$4M | 0.06% | 323 |
|
|
2024
Q1 | $47.9M | Buy |
1,117,212
+228,985
| +26% | +$9.44M | 0.08% | 295 |
|
|
2023
Q4 | $32.9M | Buy |
888,227
+6,292
| +0.7% | +$226K | 0.06% | 354 |
|
|
2023
Q3 | $32M | Sell |
881,935
-1,567
| -0.2% | -$55.6K | 0.06% | 332 |
|
|
2023
Q2 | $31.5M | Sell |
883,502
-123,435
| -12% | -$4.43M | 0.06% | 364 |
|
|
2023
Q1 | $35.8M | Sell |
1,006,937
-113,214
| -10% | -$3.96M | 0.07% | 336 |
|
|
2022
Q4 | $39.4M | Sell |
1,120,151
-3,281
| -0.3% | -$109K | 0.08% | 301 |
|
|
2022
Q3 | $33M | Buy |
1,123,432
+229,821
| +26% | +$8.71M | 0.07% | 327 |
|
|
2022
Q2 | $48.7M | Buy |
893,611
+118,189
| +15% | +$6.52M | 0.1% | 246 |
|
|
2022
Q1 | $42.2M | Buy |
775,422
+149,421
| +24% | +$8.12M | 0.07% | 325 |
|
|
2021
Q4 | $34.5M | Buy |
626,001
+89,626
| +17% | +$4.66M | 0.06% | 407 |
|
|
2021
Q3 | $25.6M | Buy |
536,375
+55,200
| +11% | +$2.77M | 0.04% | 497 |
|
|
2021
Q2 | $23.9M | Buy |
481,175
+101,153
| +27% | +$4.86M | 0.04% | 525 |
|
|
2021
Q1 | $17M | Buy |
380,022
+83,239
| +28% | +$3.78M | 0.03% | 666 |
|
|
2020
Q4 | $13.7M | Buy |
+296,783
| New | +$13.6M | 0.03% | 676 |
|
|
2020
Q1 | – | Sell |
-5,440
| Closed | -$319K | – | 3076 |
|
|
2019
Q4 | $319K | Buy |
+5,440
| New | +$303K | ﹤0.01% | 2557 |
|
|
2019
Q2 | – | Sell |
-46,198
| Closed | -$2.41M | – | 2902 |
|
|
2019
Q1 | $2.41M | Hold |
46,198
| – | – | ﹤0.01% | 1618 |
|
|
2018
Q4 | $2.21M | Buy |
46,198
+37,520
| +432% | +$1.85M | ﹤0.01% | 1562 |
|
|
2018
Q3 | $436K | Buy |
+8,678
| New | +$441K | ﹤0.01% | 2449 |
|
|
2018
Q1 | – | Sell |
-126,411
| Closed | -$5.61M | – | 2937 |
|
|
2017
Q4 | $5.61M | Buy |
+126,411
| New | +$5.84M | 0.01% | 1273 |
|
|
2017
Q2 | – | Sell |
-10,960
| Closed | -$578K | – | 2986 |
|
|
2017
Q1 | $578K | Buy |
+10,960
| New | +$556K | ﹤0.01% | 2367 |
|
Other funds holding GSK
JEST
Russell Investments Group's GSK Position: Q2 2026 in Review
Russell Investments Group reduced its GSK (GSK) stake by 1.3% in Q2 2026, selling an estimated $699K and leaving 1,038,101 shares worth $54.4M. The position accounts for 0.05% of the portfolio, ranked #378.
Russell Investments Group first reported a position in GSK in Q1 2017 and has held it in 29 quarters since. The position peaked at $57.9M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Russell Investments Group held 1,038,101 shares of GSK worth $54.4M as of Q2 2026.
- Russell Investments Group sold 13,216 GSK shares in Q2 2026, an estimated $699K.
- GSK made up 0.05% of Russell Investments Group's portfolio in Q2 2026, its #378 holding.
- Russell Investments Group first reported a position in GSK in Q1 2017 and has held it in 29 quarters since.
- Russell Investments Group's GSK position peaked at $57.9M in Q1 2026.
- 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.